atopic-dermatitis

Documents about atopic-dermatitis

• Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis#968477ClinicalTrials.gov
• A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis#1009619ClinicalTrials.gov
• BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis#869610ClinicalTrials.gov
• Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis#901583ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients#907416ClinicalTrials.gov
• An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids#995543ClinicalTrials.gov
• Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome#968556ClinicalTrials.gov
• Prebiotics in Prevention of Atopy#828947ClinicalTrials.gov
• Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.#28383ClinicalTrials.gov
• Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)#826513ClinicalTrials.gov
• Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application#854439ClinicalTrials.gov
• To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis#908905ClinicalTrials.gov
• HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers#979303ClinicalTrials.gov
• Biologics vs JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis. Long-Term Efficacy and Safety: A Systematic Review#427395HAL (France)
• Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema#829857ClinicalTrials.gov
• A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo#837273ClinicalTrials.gov
• Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis#842471ClinicalTrials.gov
• A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries#897047ClinicalTrials.gov
• A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis#980904ClinicalTrials.gov
• A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis#995482ClinicalTrials.gov
• Studies of Skin Microbes in Healthy People and in People With Skin Conditions#858571ClinicalTrials.gov
• Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis#896888ClinicalTrials.gov
• Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)#896963ClinicalTrials.gov
• Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old#904661ClinicalTrials.gov
• Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic Dermatitis#980838ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)#804850ClinicalTrials.gov
• Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis#807068ClinicalTrials.gov
• Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis#836543ClinicalTrials.gov
• Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis#836988ClinicalTrials.gov
• A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis#839173ClinicalTrials.gov
• A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color#855589ClinicalTrials.gov
• An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World#911725ClinicalTrials.gov
• Food Allergy and Philagrine Mutation in Children with Atopic Dermatitis#108989PhilArchive
• A Study of LY3471851 in Participants With Eczema#807482ClinicalTrials.gov
• Evaluate the Safety, Tolerability of BAT6026#879486ClinicalTrials.gov
• SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"#891753ClinicalTrials.gov
• Characterization of Chronic Hand Eczema#916217ClinicalTrials.gov
• Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares#899836ClinicalTrials.gov
• Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood#992114ClinicalTrials.gov
• Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study#1031807ClinicalTrials.gov
• A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists#911432ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients#883641ClinicalTrials.gov
• Targeted Microbiome Transplant in Atopic Dermatitis#903866ClinicalTrials.gov
• Restoration of Microbiota in Neonates#828008ClinicalTrials.gov
• Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064#904533ClinicalTrials.gov
• Molecular Signatures of Cutaneous Dupilumab Response#806292ClinicalTrials.gov
• Scratch Behavior Under Standard of Care#843527ClinicalTrials.gov
• A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis#842148ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis#902320ClinicalTrials.gov
• The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)#272372ClinicalTrials.gov